Epstein Secrets

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

e relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confi

al-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug companie

ents." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confid

hey include FDA approval and nationwide distribution. FDA Commissioner Hahn promised earlier on Thursday that the FDA would not "cut corners" on the Pfizer and Moderna emergency applications for their COVID vaccines. Hahn said in a statement, "I am promising you, your viewers, and the American people [

Labs Warn Of COVID Test Delays. The AP <https://apnews.com/article/us-covid-19-testing-strained-holidays- db20ebbccl fa8a411be819ebc241af3b> (11/19, Perrone, Renault) reports that testing laboratories have "warned that continuing shortages of key supplies are likely to create more bottlenecks and delays"

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

e relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confi

ey include FDA approval and nationwide distribution. FDA Commissioner Hahn promised earlier on Thursday that the FDA would not "cut corners" on the Pfizer and Moderna emergency applications for their COVID vaccines. Hahn said in a statement, "I am promising you, your viewers, and the American people [

getting ill and prevent somebody from getting seriously ill - that's huge...by anybody's standard." Labs Warn Of COVID Test Delays. The AP (11/19, Perrone, Renault) reports that testing laboratories have "warned that continuing shortages of key supplies are likely to create more bottlenecks and delays"

preterm birth and other complications. ... Pregnant women can gain some protection by getting vaccinated; recent evidence suggests the Moderna and Pfizer vaccines are safe to use in pregnancy." The AP says "the results were published on Thursday in the Journal of the American Medical Association Pedia

imate goal [is] to vaccinate every elementary school child by this time next year." Hospitalizations Drop 80% Among Senior Citizens. The AP (4/22, Perrone, Johnson) reports, "COVID-19 hospitalizations among older Americans have plunged 80% since the start of the year, dramatic proof the vaccination cam

ey include FDA approval and nationwide distribution. FDA Commissioner Hahn promised earlier on Thursday that the FDA would not "cut corners" on the Pfizer and Moderna emergency applications for their COVID vaccines. Hahn said in a statement, "I am promising you, your viewers, and the American people [

getting ill and prevent somebody from getting seriously ill - that's huge...by anybody's standard." Labs Warn Of COVID Test Delays. The AP (11/19, Perrone, Renault) reports that testing laboratories have "warned that continuing shortages of key supplies are likely to create more bottlenecks and delays"